Hollow collagen gel
The production of hollow collagen gel through a porous material and gelling agent interaction addresses solvent toxicity and cell compatibility issues, enabling efficient cell encapsulation and tissue regeneration.
Patent Information
- Application Number
- JP2021537315
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-08-05
- Filing Date
- 2020-08-04
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2040-08-04
AI Technical Summary
Conventional collagen materials used in medical devices face issues such as residual solvent toxicity, inability to encapsulate cells or large-diameter particulate drugs, and unsuitable co-culture of cells with different proliferative abilities, limiting their application in regenerative medicine and tissue regeneration.
A method of producing a hollow collagen gel by filling a collagen solution into a porous material and contacting it with a gelling agent to form a hollow structure, which can be used to encapsulate cells or drugs and facilitate co-culture of cells with different proliferation abilities.
The hollow collagen gel enables efficient encapsulation and co-culture of cells, promoting tissue regeneration and nerve regeneration, and can be used for creating artificial organs and prostheses with enhanced functionality.
Smart Images

Figure 0007591829000001 
Figure 0007591829000002 
Figure 0007591829000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a hollow collagen gel and a method for producing the same. [Background technology]
[0002] Collagen materials are widely used as surgical medical devices (TERUMO: Terudermis, GUNZE: Pernac). In recent years, they have also been attracting attention in the development of new medical technologies, including regenerative medicine.
[0003] Conventional collagen materials include sponge-like or membrane-like products made by vacuum drying. In recent years, a thread-like collagen that assists in nerve regeneration has been launched on the market (NIPRO: Renerve). This product is formed as a thread-like hydrogel by discharging collagen into an organic solvent. The thread-like collagen can be used as a suture for tissue ruptures, a cell carrier seeded with cells, and a cell migration inducer in tissue regeneration. Since tissues are composed of epithelial cells and mesenchymal cells, their regeneration requires the simultaneous transplantation of different cells, including parenchymal cells (e.g., epithelial cells) and mesenchymal cells (e.g., vascular endothelium).
[0004] However, the above method leaves organic solvents behind, and so solving the toxicity problem is an issue. In particular, when the material is filamentous, it is impossible to encapsulate cells or large-sized granular drugs inside the material, which is a cell carrier required for regenerative medicine. Furthermore, when two or more types of cells are seeded on the surface of the filamentous material, the cells with low proliferation ability are eliminated by the cells with high proliferation ability, making it unsuitable for use as a culture carrier.
[0005] On the other hand, the present inventors discovered that thread-like atelocollagen can be produced by irradiating a cylindrical hydrogel with ultraviolet light, vitrifying it, and rehydrating it (Non-Patent Document 1: Biomater Sci. 2019 7(1):125-138).
[0006] As a technique for producing a tubular tissue, the formation of a high-density, highly oriented collagen tubular tissue utilizing the contractility of smooth muscle cells and the possibility of application to ultra-small diameter artificial blood vessels are known (Non-Patent Document 2: Kanda Keiichi, Oka Takahiro, Matsuda Takehisa - Artificial Organs, 1994), and collagen tubes characterized by having walls formed by a continuous, cylindrical, coaxial collagen film are also known (Patent Document 1: JP-T-2009-540896). Furthermore, as a method for producing a collagen tube, JP-A-48-033686 (Patent Document 2) discloses molding using a cylindrical nozzle, and JP-A-2011-130995 (Patent Document 3) discloses a method for molding by inserting a rod-shaped member into the inside of the tube of a luminal collagen structure. In addition, JP-B-04-035185 (Patent Document 4) discloses a molding method using a cylindrical nozzle, GB1007978 (Patent Document 5) discloses an extruded collagen tube containing collagen fibrils, and FR2902661 (Patent Document 6) discloses a method of rolling a collagen film into a tubular shape. [Prior art documents] [Patent documents]
[0007] [Patent Document 1] Special Publication No. 2009-540896 [Patent Document 2] Japanese Unexamined Patent Publication No. 48-033686 [Patent Document 3] JP 2011-130995 A [Patent Document 4] Special Publication No. 04-035185 [Patent Document 5] GB1007978 publication [Patent Document 6] FR2902661 publication [Non-patent literature]
[0008] [Non-Patent Document 1] Biomater Sci. 2019 7(1):125-138 [Non-Patent Document 2] Keiichi Kanda, Takahiro Oka, Takehisa Matsuda - Artificial Organs, 1994 Summary of the Invention [Problem to be solved by the invention]
[0009] In hollow fiber collagen material, vascular endothelial cells are enclosed inside and parenchymal cells such as epithelial cells are seeded on the outside, which allows for easy co-culture of cells without having to consider differences in proliferation ability, making it a groundbreaking transplant device that reproduces a basic tissue structure with a vascular network. In nerve tissue regeneration, it is expected to achieve a much higher rate of nerve regeneration than existing products by seeding nerve cells inside and Schwann cells on the outside. Furthermore, this hollow fiber collagen material can be used to easily create artificial organs by combining different cells in each hollow fiber and bundling them together. Therefore, there has been a demand for the development of a method for producing hollow collagen gel more easily than the conventional methods for producing hollow fiber-type collagen materials.
[0010] As a result of intensive research into solving the above problems, the present inventors succeeded in forming a hollow collagen gel by impregnating a gelling agent into collagen enclosed in a material having holes (for example, a hollow tube or a hollow cylindrical container), thereby completing the present invention. [Means for solving the problem]
[0011] That is, the present invention includes the following embodiments. (1) A method for producing a hollow collagen gel, comprising contacting a collagen solution filled in the pores of a porous material with a gelling agent. (2) The method according to (1), wherein the hollow collagen gel formed in the pores by the contact is discharged from the pores into a gelling agent. (3) The method according to (1) or (2), wherein the hollow collagen gel is in the form of a hollow fiber. (4) The method according to any one of (1) to (3), wherein the concentration of the collagen solution is 0.5 wt% to 3.0 wt%. (5) The method according to any one of (1) to (4), wherein the gelling agent has a pH of 7 to 13. (6) The method according to any one of (1) to (5), wherein the inner diameter of the holes in the material having holes is 0.1 mm to 2 mm. (7) A hollow collagen gel produced by the method according to any one of (1) to (6). (8) A hollow collagen gel having an inner diameter of 0.05 mm and an outer diameter of 0.2 mm to 5 mm. (9) A medical material, characterized in that cells are seeded on the inner or outer wall of the collagen gel according to (7) or (8). (10) The material described in (9), wherein the cells are endothelial cells. (11) The medical material according to (9) or (10), which is for use in blood vessels or nerves. This specification includes the disclosures of Japanese Patent Application No. 2019-143860, which is the priority basis of this application. Effect of the Invention
[0012] The present invention provides a hollow collagen gel. The hollow collagen gel produced by the present invention can be used for (i) a cell, drug or bacterial cell encapsulation device, (ii) a heterologous cell co-transplantation device, (iii) a cell transplantation device provided with capillaries, (iv) a hollow fiber for producing an extracorporeal artificial organ, etc. The hollow thread is expected to greatly contribute to improving the functionality of the thread, for example by allowing it to contain drugs inside the thread that promote rapid healing after suturing. [Brief description of the drawings]
[0013] [Figure 1] FIG. 1 is a schematic diagram of a method for producing a hollow collagen gel of the present invention. [Diagram 2] FIG. 13 is a graph showing the collagen concentration at which hollow gels are formed. [Diagram 3] FIG. 13 is a diagram showing the relationship between the capillary diameter and the cavity diameter. [Figure 4]FIG. 13 is a diagram showing that the lumen of a hollow fiber can be covered with endothelial cells. [Diagram 5] A schematic diagram of an experiment in which collagen gel threads were prepared using a syringe is shown on the left, and the results are shown on the right. [Figure 6] This figure shows the presence or absence of endothelial cell coverage of the hollow fiber lumen for two types of collagen gels. (A) shows the results for a collagen gel prepared according to the procedure described in Example 2 of the present application, and (B) shows the results for a collagen gel prepared according to the manufacturing method described in Example 1 of JP 2019-123845 A. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0014] In one embodiment, the present invention relates to a method for producing a hollow collagen gel (a hollow tube made of collagen gel) by contacting a collagen solution filled in a material having holes (a container with holes) with a gelling agent, and to a hollow collagen gel. In one embodiment, the present invention relates to a method for producing a hollow collagen gel, which includes contacting a collagen solution filled in the pores of a material having holes with a gelling agent.
[0015] The present invention was made based on the discovery that when a collagen solution filled into the pores of a porous material is brought into contact with a gelling agent, the collagen solution gels and undergoes contraction accompanying gelation, forming a hollow space. In one embodiment, in the present invention, a collagen solution is filled into a material having holes, such as a hollow, elongated tube or a hollow, cylindrical container, and then one side of the holes in the material having holes is sealed and a gelling agent is contacted from the other side, thereby gelling the collagen solution and making the collagen gel hollow. In another aspect of the present invention, even if the material has a three-dimensional porous structure with countless pores and the pores are curved and intricate, the shape is not particularly limited as long as the filled collagen solution forms a cavity.
[0016] The collagen used as the raw material is not particularly limited, and commercially available collagen can be used. The origin of the animal is also not limited, and collagen derived from, for example, pigs, cows, fish, or birds can be used. The concentration of the collagen solution is, for example, 0.5 to 3% by weight (wt%), preferably 1% by weight. The solvent for the collagen solution is not particularly limited as long as it is an aqueous solvent. The aqueous medium may contain alcohol, glycerin, a surfactant, etc.
[0017] The gelling agent for gelling the collagen solution is not particularly limited, and any of a solution, a gas, and a solid can be used. When the gelling agent is in the form of a solution, examples of the gelling agent include buffer solutions such as PBS, EDTA, Tris-HCl, TE, TAE, SSC, TBE, SSPE, phosphate buffer, carbonate-bicarbonate buffer, sodium citrate buffer, borate buffer, HEPES, BES, MOPS, TES, TAPSO, POPSO, HEPSO, EPPS, Tricine, Bicine, TAPS, CHES, CAPS, etc. The pH of the gelling agent is 7 to 13.
[0018] When the gelling agent is a gas (used as vapor), the gelling agent is not particularly limited as long as it becomes a basic solution when the vapor is dissolved in water, and examples of the gelling agent include ammonia gas, methylamine, and ethanolamine. When the gelling agent is a solid, examples of the gelling agent include sodium carbonate, sodium acetate, sodium hydrogen carbonate, sodium hydroxide, and potassium hydroxide.
[0019] In one embodiment, the method of the present invention does not require a gelation control agent in the gelation step. A gelation control agent is a substance that changes the presence or absence of gelation or its speed, and is different from a gelling agent. Examples of gelation control agents include acids such as hydrochloric acid, sulfuric acid, and acetic acid that adjust the pH; bases such as sodium hydroxide and ammonia; electrolytes such as table salt that change the ionic strength; and combinations of these. When a "gelation control agent" is not used, the number of components used is smaller than when a gelation control agent is used, and the production method is simpler.
[0020] The material having holes is not particularly limited, but is preferably made of plastic (Teflon, polystyrene, polyethylene, etc.) or glass. The inner diameter (diameter of the hollow part) of the material having holes may be, for example, 0.05 mm or more, 0.1 mm or more, or 0.2 mm or more, and may be 2.0 mm or less, 1.9 mm or less, 1.8 mm or less, 1.7 mm or less, 1.6 mm or less, 1.5 mm or less, 1.4 mm or less, 1.3 mm or less, 1.2 mm or less, 1.1 mm or less, or 1.0 mm or less. The inner diameter (diameter of the hollow part) of the material having holes is, for example, 0.1 mm to 2.0 mm, 0.1 mm to 1.0 mm, preferably 0.2 mm to 1 mm. Capillaries and substrates with holes can also be used.
[0021] Next, a method for gelling a collagen gel by contacting a collagen solution with a gelling agent will be described below. In one embodiment, one side of the material having holes is in contact with the gelling agent, and the other side is not in contact with the gelling agent. For example, when the gelling agent is a solution, one side of the material having holes is covered with a sealing seal, and the other side is covered with a semipermeable membrane such as a dialysis membrane, and the gelling agent is allowed to permeate from the side covered with the semipermeable membrane. For example, as shown in FIG. 1, the gelling agent is permeated by covering one side of a cylindrical container with a fluorine seal and the other side with a dialysis membrane, and sealing with a sealing tape or silicone rubber. Then, the container is immersed in the gelling agent so that the gelling agent can permeate the dialysis membrane. The immersion time is 10 minutes to 10 days, and the reaction temperature between the collagen solution and the gelling agent during immersion is 0 to 37°C. As a result, the gelling agent acts on the collagen filled in the container through the dialysis membrane to gel the collagen, and the collagen gel becomes hollow due to contraction accompanying gelation.
[0022] In one embodiment, in the method described herein, the hollow collagen gel formed in the pores by the contact is discharged from the pores into the gelling agent. In this case, the gel can be continuously prepared by discharging the gelling agent at a speed slower than the speed at which the gel is formed by the contact. The discharge speed depends on the shape of the container in which the discharge is performed, and is not limited, but may be, for example, 100 mm / h or less, 50 mm / h or less, 20 mm / h or less, 15 mm / h or less, or 10 mm / h or less, and may be 1 mm / h or more, 2 mm / h or more, or 5 mm / h or more. In this specification, "continuously preparing a gel" means that the formation of a gel by contacting the collagen solution with the gelling agent is continuously performed, and includes not only the case where the gel is prepared without a rest period, but also the case where the gel is prepared multiple times with a rest period in between. By continuously preparing the gel, it is possible to prepare a thread longer than the total length of the pores of the material having the pores. Continuous gel preparation can be carried out, for example, by filling a container such as a syringe with a gelling agent and discharging the collagen solution from a discharge part such as a needle. In this case, the needle corresponds to the material having a hole, where the gel is formed. Discharging the gel can be done manually or mechanically to precisely control the discharge speed.
[0023] The inner diameter of the hollow collagen gel thus produced (the diameter of the hollow part of the collagen gel tube) is, for example, 0.01 mm to 2.0 mm, preferably 0.05 mm to 1 mm or 0.1 mm to 0.6 mm. The outer diameter of the hollow collagen gel (the diameter of the collagen gel tube) is, for example, 0.1 mm to 2.0 mm, 0.1 mm to 1.0 mm, preferably 0.2 mm to 1 mm. The outer diameter of the hollow collagen gel may be the same as the inner diameter of the material having the holes.
[0024] The length of the hollow collagen gel thus produced may be, for example, 3 cm or more, 4 cm or more, 5 cm or more, 8 cm or more, 10 cm or more, 15 cm or more, or 20 cm or more. The length of the hollow collagen gel may be 100 m or less, 10 m or less, less than 1 m, or 50 cm or less.
[0025] In one embodiment, the collagen gel described herein is in the form of a hollow fiber. The collagen gel described herein can provide a long and thin hollow fiber, so that when used as a suture, it can provide a thread that meets the standard (e.g., JIS medical silk suture). In addition, when heterogeneous cells are aligned and interwoven in the hollow fiber to create a three-dimensional cell tissue, it may be possible to prepare a variety of dense tissues.
[0026] In one embodiment, the present invention relates to a medical material comprising the collagen gel described herein, in which cells are seeded on the inner or outer wall of the collagen gel. It has been reported that when a collagen material is used as a culture carrier, the physiological function of cells can be enhanced compared to when a polystyrene, polycarbonate, or other material is used as a culture carrier (see, for example, Ko JA et al., Invest. Ophthalmol. Vis. Sci., 2008, 49(1), pp. 113-9, and Ko JA et al., Invest. Ophthalmol. Vis. Sci., 2009, 50(5), pp. 2054-60).
[0027] In one embodiment, the cells seeded on the inner wall of the collagen gel may be endothelial cells, and the cells seeded on the outer wall may be parenchymal cells such as epithelial cells. By enclosing vascular endothelial cells inside the collagen gel described herein and seeding parenchymal cells such as epithelial cells on the outside, co-culture of cells can be easily performed without considering the difference in proliferation ability, and a transplant material that reproduces a tissue structure having a basic vascular network can be prepared.
[0028] In one embodiment, the cells seeded on the inner wall of the collagen gel may be nerve cells, and the cells seeded on the outer wall may be Schwann cells. Such a collagen gel can be used for nerve tissue regeneration and can have a high nerve regeneration effect.
[0029] In one embodiment, the medical materials described herein are for vascular or neurological applications.
[0030] Working Example The present invention will be described in more detail below with reference to examples, although the scope of the present invention is not limited to these examples. EXAMPLES
[0031] method A glass capillary tube (inner diameter: 0.47, 1.05, or 1.89 mm) was filled with 1, 3, or 6 wt% porcine collagen solution (manufactured by Nippon Ham Co., Ltd.). One end of the capillary tube was sealed with fluorine sealing tape. This was immersed in a buffer solution (pH 10) and left to stand in a refrigerator (7°C) for 5 days.
[0032] result Cavities were confirmed in the gel prepared with a collagen concentration of 1 wt% (Figure 2, inner diameter: 0.47 mm). No cavities were confirmed in the gels prepared with collagen concentrations of 3 or 6 wt%. It was confirmed that the shrinkage rate calculated from the gel cavity diameter was larger as the capillary diameter was smaller (Figure 3). This result suggests that the osmotic pressure applied from the buffer solution and the gel / glass interface are involved in the formation of cavities. The xerogels reswelled in distilled water and PBS and air-dried reached equilibrium swelling after 24 hours (distilled water: 2.8, PBS: 2.5) and maintained their shape thereafter. It was revealed that the swelling degree was larger in distilled water than in phosphate buffer. EXAMPLES
[0033] method Preparation method of hollow fiber: A 1 wt% porcine collagen solution (manufactured by Nippon Ham) was filled into a PTFE capillary tube with an inner diameter of 1 mm, and one end of the capillary tube was sealed with fluorine sealing tape in the same manner as in Example 1, and the tube was immersed in a carbonate buffer solution (pH 10) for about 5 days to prepare a hollow collagen gel. After gelation, the fluorine sealing tape at one end was removed, and the gel in the capillary tube was pushed out with a dropper to remove the collagen gel from the capillary tube. The removed gel was hung from one end on a glass rod and air-dried at 20°C and 60% humidity for 1 day to obtain a xerogel.
[0034] The hollow fiber collagen gel was placed in a 10 cm diameter culture dish, mixed with 1 million endothelial cells per 10 ml of culture medium, and cultured in a static manner to seed the endothelial cells (cell line, MS-1, ATCC) in the collagen gel. The medium was changed every two days.
[0035] On the seventh day after seeding, the hollow fiber collagen gels were fixed in formalin, embedded in paraffin, and then sliced. The adhesion and distribution of cells were confirmed by HE staining.
[0036] result It was confirmed that the inner lumen of the hollow fiber could be covered with endothelial cells (Figure 4). EXAMPLES
[0037] method Collagen gel threads were prepared using a syringe according to the following procedure. (a): A 1 wt% porcine collagen solution (manufactured by Nippon Ham) was used. (b): A carbonate buffer solution (pH 10) was used as the buffer solution, and 20 ml was placed in a vial. (c): A PTFE tube (50 mm long) with an inner diameter of 1.89 mm was attached to the tip of a 10 ml plastic disposable syringe. (d): 6 ml of the collagen aqueous solution (a) was sealed in a syringe equipped with a PTFE tube. (e): After pushing out the collagen to the tip of the PTFE tube (d), it was inserted into the buffer solution (b) and the collagen solution was brought into contact with the buffer solution (b), and left for 2 days. (g): After this leaving, the collagen solution was discharged into the buffer solution at 10 mm / h using a microsyringe pump, and collagen gel threads were obtained.
[0038] result A schematic diagram of this experiment is shown on the left side of Figure 5, and the results are shown on the right side of Figure 5. The lengths of the prepared collagen gel threads ranged from 6 cm to 15 cm. EXAMPLES
[0039] method The adhesion and proliferation of vascular endothelial cells to the hollow interior of a collagen gel prepared according to the procedure described in Example 2 of the present application and a collagen gel prepared according to the procedure described in Example 1 of JP 2019-123845 A were compared.
[0040] The collagen gel was placed in a 10 cm diameter culture dish, mixed with 1 million endothelial cells per 10 ml of culture medium, and cultured in a static manner to seed the endothelial cells (cell line, MS-1, ATCC) on the collagen gel. The medium was changed every two days. On the 7th day after seeding, the collagen gel was fixed in formalin, embedded in paraffin, and then sliced. The adhesion and distribution of cells were confirmed by HE staining.
[0041] result The results are shown in Figure 6. In the collagen gel prepared according to the procedure described in Example 2 of the present application, images of endothelial cell coverage (proliferation) were observed on the outside of the material and on the hollow lumen surface (arrow). On the other hand, in the collagen gel prepared according to the manufacturing method described in Example 1 of JP 2019-123845 A, images of vascular endothelial cell coverage were observed on the outside of the material (arrowhead), but no images of cells were observed on the lumen (star).
[0042] All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety.
Claims
1. A method for producing a hollow collagen gel, comprising contacting a collagen solution filled in pores of a porous material with a gelling agent, the method comprising the steps of: The hollow collagen gel formed in the pores by the contact is discharged from the pores into a gelling agent, The method, wherein the gelling agent is a buffer having a pH of 7 to 13.
2. A method for producing a hollow collagen gel, comprising contacting a collagen solution filled in pores of a porous material with a gelling agent, the method comprising the steps of: One side of the material having holes is covered with a sealing seal and the other side is covered with a semipermeable membrane, and the gelling agent is allowed to permeate from the side covered with the semipermeable membrane, thereby bringing the collagen solution into contact with the gelling agent; The method, wherein the gelling agent is a buffer having a pH of 7 to 13.
3. The method according to claim 1 or 2, wherein the hollow collagen gel is in the form of a hollow fiber.
4. The method according to any one of claims 1 to 3, wherein the concentration of the collagen solution is 0.5 wt% to 3.0 wt%.
5. 5. The method according to claim 1, wherein the inner diameter of the pores in the material having holes is between 0.1 mm and 2 mm.
6. A hollow collagen gel produced by the method according to any one of claims 1 to 5 (excluding those having an outer shell layer containing a high-strength hydrogel covering the outer periphery of the collagen gel).
7. 7. The hollow collagen gel according to claim 6, having an inner diameter of 0.05 mm and an outer diameter of 0.2 mm to 5 mm.
8. A medical material comprising the collagen gel according to claim 6 or 7, wherein cells are seeded on the inner or outer wall of the collagen gel.
9. The material of claim 8 , wherein the cells are endothelial cells.
10. The medical material according to claim 8 or 9, which is for use in blood vessels or nerves.
Citation Information
Patent Citations
Collagen tube for e.g. regeneration of severed nerve, has wall constituted by succession of co-axial, cylindrical, continuous and non-porous collagen films, where each film has specific thickness, and tube has specific length
FR2902661A1
Extruded collagen tube particularly for use as sausage casing
GB1007978A
JP1973033686A
Video signal optical transmission system
JP1992035185A
Biocompatible polymer conjugates
JP1996502082A
